Janssen EMEA Marks World Mental Health Day with Schizophrenia Tweetchat
Tweetchat encourages open discussion
The Tweetchat will take place at 1:00pm CET today, and we would like to encourage you to join! It will cover topics such as the impact of schizophrenia, stigma surrounding the condition, and how to encourage open discussion between healthcare professionals and patients living with schizophrenia. Those interested can follow questions asked from the @talkhealth twitter account using the hashtags #TalkSchizophrenia and #WMHD17. Janssen will share the outcomes and conclusions of the discussion later this month.
Some questions Tweetchat followers can expect:
What’s the best way to look after your mental health?
We’ve come a long way in destigmatising mental health issues such as anxiety and depression, why does schizophrenia remain a taboo?
How can we address the stigma faced by people living with schizophrenia?
What are the major barriers to open conversations between patients and healthcare professionals?
How can we help support people living with schizophrenia?
Diagnosis animation – participation in treatment choices
The animation chronicles the journeys of two people living with schizophrenia: Sally, who was recently diagnosed with schizophrenia and Raj who has been diagnosed for 15 years.
For both Sally and Raj, and anyone living with schizophrenia, the right treatment plan plays an important role in achieving long-term goals and living a fulfilling life. Being aware of all available treatment choices means that people living with schizophrenia can participate in the decision-making process, and have an open discussion with their doctor and carer about what they would like from their treatment plan.
Schizophrenia is a complex and chronic brain disorder, in which symptoms can be severe and disabling and can affect all aspects of a person’s daily life. Schizophrenia is typically a lifelong condition, but there are treatments that can be beneficial. Clinical guidelines recommend that the optimal treatment package is a combination of antipsychotic medication along with psychotherapy, psycho-education and self-help. Effective treatment may allow people with the condition to enjoy a more fulfilling, well rounded life, which may include returning to work or study, independent living and social relationships, which in turn can aid their recovery.1
At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it.
For more information on our activities in this area, we invite you to explore our neuroscience pages.
1. Lang U, Puls I, Muller DJ et al. Molecular mechanisms of schizophrenia. Cell Physiol Biochem 2007;20(6):687-702.